Latest News from Pro PG

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group (ProPG) advises that due to a shortage of Australian registered BENPEN benzylpenicillin (as sodium)

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. ​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 25mg Tablets until 30th September

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered products on a temporary basis: XYL

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered Gemfibrozil products on a tempora

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered tocilizumab products on a temporar

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Pro Pharmaceuticals Group has arranged for the supply of the following overseas registered tocilizumab products on a temporar

Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. ​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 25mg Tablets until 30th June 2021.

Pro PG has gained an account with Onelink New Zealand which will allow them to supply New Zealand Hospitals Unlicensed Medicines to meet their unmet medical needs. Onelink is owned by the EBOS Group and this will allow Pro Pharm to distribute to NZ Hospitals.